Schedule 13G ownership disclosure
MERSANA THERAPEUTICS INC
Common Stock · CUSIP: 59045L106
Event date: 2025-03-31
- Filing-level shares
- 8,377,767
- Percent of class
- 6.72%
- The Vanguard Group
Shares: 8,377,767 · Class: 6.72%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000640
- Form type
- SCHEDULE 13G/A
- Filer
- Mersana Therapeutics, Inc.
- CIK
- CIK 1442836
- Filed
- Apr 30, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership